These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2837590)

  • 1. Flow cytometric analysis of comedocarcinoma of the prostate: an uncommon histopathological variant of prostatic adenocarcinoma.
    Currin SM; Lee SE; Walther PJ
    J Urol; 1988 Jul; 140(1):96-100. PubMed ID: 2837590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence.
    Lee SE; Currin SM; Paulson DF; Walther PJ
    J Urol; 1988 Oct; 140(4):769-74. PubMed ID: 3047437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic comedocarcinoma: correlation of sonograms with pathologic specimens in three cases.
    Lile R; Thickman D; Miller GJ; Crawford ED
    AJR Am J Roentgenol; 1990 Aug; 155(2):303-6. PubMed ID: 2164763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of abnormal diploid DNA histograms in localized prostate cancer and adjacent benign prostatic tissue.
    Deitch AD; Miller GJ; deVere White RW
    Cancer; 1993 Sep; 72(5):1692-700. PubMed ID: 7688657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA heterogeneity in prostatic adenocarcinoma. A DNA flow cytometric mapping study with whole organ sections of prostate.
    O'Malley FP; Grignon DJ; Keeney M; Kerkvliet N; McLean C
    Cancer; 1993 May; 71(9):2797-802. PubMed ID: 8467459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA flow cytometric study of the hyperplastic and neoplastic canine prostate.
    Madewell BR; Deitch AD; Higgins RJ; Marks SL; deVere White RW
    Prostate; 1991; 18(2):173-9. PubMed ID: 1706513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma.
    Nativ O; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
    J Urol; 1990 Aug; 144(2 Pt 1):303-6. PubMed ID: 1695690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA heterogeneity determined by flow cytometry in prostatic adenocarcinoma--necessitating multiple site analysis.
    Warzynski MJ; Soechtig CE; Maatman TJ; Goldsmith LC; Grobbel MA; Carothers GG; Shockley KF
    Prostate; 1995 Dec; 27(6):329-35. PubMed ID: 7501545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous flow cytometric deoxyribonucleic acid and acid phosphatase analysis of benign and malignant lesions of the prostate.
    Schultz RE; Varello MA; Tsou KC; Wein AJ; Murphy JJ
    J Urol; 1985 Dec; 134(6):1133-6. PubMed ID: 4057403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow cytometry in prostate cancer. Evaluation of its feasibility for biopsy specimens and correlation with grading].
    Ferrara G; Monaco R; Capasso A; Bellomo PF; Fruttero A; Pugno F; Nappi O; Ruà S
    Pathologica; 1998 Feb; 90(1):14-9. PubMed ID: 9628974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason grade 4 and 5, and lymph node metastases.
    Jones EC; McNeal J; Bruchovsky N; de Jong G
    Cancer; 1990 Aug; 66(4):752-7. PubMed ID: 2386903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy and the expression of tissue-carcinoembryonic antigen in grade III carcinoma of the breast.
    van Dam PA; Keersmaeckers G; Van Bockstaele DR; Uyttenbroeck FL
    Eur J Obstet Gynecol Reprod Biol; 1991 Jan; 38(1):59-62. PubMed ID: 1846341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric determination of ploidy in prostatic adenocarcinoma and its relation to clinical outcome.
    Blatstein LM; Ginsberg PC; Daskal I; Finkelstein LH
    J Am Osteopath Assoc; 1993 Apr; 93(4):463-8, 471-2. PubMed ID: 8478220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyribonucleic acid flow cytometry of benign prostatic disease.
    Deitch AD; Strand MA; de Vere White RW
    J Urol; 1989 Sep; 142(3):759-62. PubMed ID: 2769856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric determination of breast tumor heterogeneity.
    Fuhr JE; Frye A; Kattine AA; Van Meter S
    Cancer; 1991 Mar; 67(5):1401-5. PubMed ID: 1846776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radical prostatectomy.
    Brown JA; Slezak JM; Lieber MM; Jenkins RB
    Mayo Clin Proc; 1999 Dec; 74(12):1214-20. PubMed ID: 10593349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor expression and DNA content of paraffin-embedded archival human prostate tumors.
    Adiga SK; Andritsch I; Rao RV; Krishan A
    Cytometry; 2002 Feb; 50(1):25-30. PubMed ID: 11857595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathological features of highly malignant prostatic carcinomas with metastases to the penis.
    Buchholz NP; Moch H; Feichter GE; Schmid HP; Mihatsch MJ
    Urol Int; 1994; 53(3):135-8. PubMed ID: 7645139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison between nuclear DNA and histologic grade of prostatic carcinoma].
    Zattoni F; Prayer Galetti T; Vianello F; Bertoldin R; Panozzo M; Blandamura S; Costantin G
    J Urol (Paris); 1992; 98(4):192-5. PubMed ID: 1284300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
    Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
    Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.